Curebase, InBios tout results of virtual COVID-19 trial
July 14, 2021 -- Diagnostic test developer InBios successfully used Curebase's virtual platform to power clinical studies for its SCoV-2 Ag Detect test for rapid detection of SARS-CoV-2 infection, including at drive-through sites in California. Read More
NanoDx inks deal with IBM, seeks EUA for COVID-19 test
July 14, 2021 -- NanoDx announced that it has signed a licensing deal with IBM Research and will pursue an emergency use authorization (EUA) from the U.S. Food and Drug Administration for a rapid COVID-19 test. Read More
Longhorn touts study of collection device for COVID/flu testing
July 9, 2021 -- Longhorn Vaccines & Diagnostics touted study results in the Journal of Applied Laboratory Medicine that supported the advantages of the company's PrimeStore Molecular Transport Medium with the Roche Cobas Liat System for SARS-CoV-2 and influenza detection. Read More
With Hitachi deal done, Fujifilm sets sights on healthcare growth
July 2, 2021 -- Fresh off its acquisition of Hitachi's medical imaging business, Japanese industrial giant Fujifilm on July 1 rebranded its healthcare subsidiaries in the U.S. and Europe to reflect the newly integrated company. The deal exemplifies Fujifilm's plan to make healthcare its primary business. Read More
Point-of-care developer DCN Dx acquires IVD Vision
July 2, 2021 -- Point-of-care diagnostics company DCN Dx announced it has completed the acquisition of IVD Vision, a developer of custom instruments and software for diagnostics systems. Read More
FDA grants EUA for Diabetomics' SARS-CoV-2 Ab test
June 24, 2021 -- Diabetomics announced the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for its CovAb SARS-CoV-2 Ab point-of-care test. Read More
DCN Dx acquires PortaScience
June 21, 2021 -- DCN Dx has closed its acquisition of PortaScience, a dry chemistry-focused, point-of-care diagnostics development company. Read More
Ink dries on Hologic's deal to buy Mobidiag
June 17, 2021 -- Hologic announced the completion of its $808 million acquisition of biotechnology company Mobidiag. The Finnish-French company develops near-patient, acute-care molecular diagnostic testing products. Read More
NowDiagnostics gets EUA for point-of-care COVID test
May 28, 2021 -- NowDiagnostics has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for AdexusDx, a point-of-care test to detect antibodies to SARS-CoV-2, the virus that causes COVID-19. Read More
Market for biomarker-based infectious disease tests to hit $15B
May 26, 2021 -- Even excluding COVID-19 diagnostics, infectious disease biomarker technologies are driving growth in the diagnostic biomarker sector, according to Bruce Carlson of Kalorama Information. Read More